5th FIP Pharmaceutical Sciences World Congress Melbourne, Australia 13-16 April 2014

 

FIP 2014


5th FIP Pharmaceutical Sciences
World Congress (PSWC)

Melbourne, Australia 13-16 April 2014‘Pharmaceutical Sciences beyond 2020 – The rise of a new era in healthcare’

Dear colleague in Pharmaceutical Sciences,We are pleased to announce to you that registration for PSWC 2014 is officially open! Please click here and discover the only truly International Pharmaceutical Sciences Congress.Attend PSWC 2014 to:

  • Network with key leaders in pharmaceutical sciences from all over the world
  • Learn from leading experts on what will happen beyond 2020
  • Enjoy hearing high level speakers recount their latest research findings in plenaries, keynotes, workshops, debates, roundtables and unique regional showcases
  • Attend the parallel APSA (Australasian Pharmaceutical  Science Association) and DDA (Drug Delivery Australia) congresses
  • Enjoy beautiful Melbourne, known as ‘the world’s most livable city’


Co-sponsored by many of the world’s leading pharmaceutical science and educational organisations, the International Pharmaceutical Federation (FIP) is pleased to bring the 5th PSWC to Melbourne, Australia in 2014.Not only will the congress uphold its world- renowned reputation for top quality speakers, symposia and posters, but will once again provide a forum for the most extensive international network of scientists to make an impact on the future of pharmaceutical sciences and global healthcare.

 

Abstract submission: present your research in the global arena

The categories to submit abstracts are:

  • Drug Design and Discovery
  • Natural Products
  • Formulation Design and Pharmaceutical Technology
  • Pharmacokinetics (PK), Pharmacodynamics (PD) and Systems
  • Pharmacology
  • Translational Research and Individualized Medicines
  • Biotechnology (including Vaccines)
  • Analytical Sciences and Pharmaceutical Quality
  • Regulatory Sciences (including Dissolution/In vitro drug release, BCS and Biowaivers, BA/BE and Clinical Bridging Studies)
  • Pharmacoepidemiology and Health Technology Assessment

The deadline to submit abstracts is: 1 December 2013

 

Special program for studentsStudents love Melbourne and at the 5th Pharmaceutical Sciences World Congress, students will be welcomed as never before. Through interactive programming featuring leading international authorities across multiple disciplines, PSWC 2014 will offer students deep insights into the future direction of the pharmaceutical sciences.You will learn about emerging pharmaceutical markets with a major focus on the dynamic Asia Pacific sector and hear of industry trends that will shape your future. Our unique Australian style exhibition and showcase will provide unique student opportunities including a career centre and opportunities for direct engagement with global pharmaceutical science leaders. Fun, student centred social activities throughout the Congress will also ensure you have a time to remember.No Congress will provide a better platform for you to shape your career as we head towards 2020.

 

Sponsoring and Exhibition

PSWC will play host to a three day exhibition. Exhibitors and sponsors are invited to take advantage of extensive, high quality showcase opportunities, bringing the best of their products, services and organizations to the public eye. Read more

PSWC 2014: The only truly international Pharmaceutical Sciences Congress

 

Registration open!

 



Join our Linkedin group, main channel for PSWC News

 


Emirates Airline – Official Partner airline for PSWC 2014. More informationhere.



Daily News

Get your daily dose of Pharmacy news from all over the globe.
FIP on Facebook

FIP on
Linkedin

FIP on
Twitter
 

FIP Congress on Facebook

 

 



Contacting fip

PO Box 84200
2508 AE The Hague
The NetherlandsTel.: +31-70-3021970
Fax: +31-70-3021999
Email: pswc@fip.org

 


Update your contact information

Please click here to view or change your contact information and your preferences.

Pharmaceutical Society of China Taiwan

 
  • Information

8F., No.74, Sec. 2, Xinyi Rd., Da-an Dist., Taipei City 106, Taiwan (R.O.C.)

Tel.: +886-2-2327-8623
Fax: +886-2-2396-7261
E-mail: pharmtw@gmail.com
Web: www.pharm.org.tw

International

who

WHO-WHO Donates Incubators, Drug Refrigerator For Children’s Ward in Kiribati 

KIRIBATI, 30 April 2012 – Three state-of-the-art incubators are saving the lives of at-risk newborns in this Pacific island country thanks to a donation from the World Health Organization (WHO) Regional Office for the Western Pacific.

On 7 March, WHO Country Liaison Officer Dr André Reiffer handed over the incubators and a refrigerator for paediatric drugs to Minister for Health and Medical Services Dr Kautu Tenaua at the children’s ward of Tungaru Central Hospital on Tarawa atoll.

who

WHO-WHO Report Reveals Teenagers Do Not Get a Fair Deal on Health

02 May-WHO/Europe has published the latest report from the Health Behaviour in School-aged Children (HBSC) study, based on interviews with over 200 000 young people. The study collects data and produces an international report every four years on the health, well-being, social environments and health behaviours of 11-, 13- and 15-year-old boys and girls.

Professor Candace Currie, the study’s International Coordinator, explains some of its key findings, current trends and how HBSC began.

who

WHO-Scaling up The Fight against Malaria

25 April 2012 — On World Malaria Day 2012, WHO hails global progress in combating malaria, but highlights the need to reinforce the fight. WHO’s new initiative, T3: Test, Treat, Track, urges malaria-endemic countries and donors to move towards universal access to diagnostic testing and antimalarial treatment, and to build robust malaria surveillance systems.

who

WHO-Preterm Baby Mortality Can Be Reduced by Three-Quarters

2 May 2012 — Each year, some 15 million babies in the world – more than one in 10 births – are born too early, according to the report Born too soon: the global action report on preterm birth. The report shows significant drops in mortality rates in countries where front-line workers are trained and have access to life-saving supplies for preterm babies, even without expensive health technology. Such practices if implemented globally could reduce deaths by three-quarters worldwide.

who

WHO-Haiti: Free Obstetric Care Saving Lives

April 2012/ “This is my first child. I attended two prenatal consultations at the hospital. I did not have problems during pregnancy but I did have complications during the birth and am happy I delivered at the hospital. At home the baby could have died.”

who

WHO-Good Hand Hygiene Promotes Patient Safety

4 MAY 2012 | GENEVA – On Hand Hygiene Day (5 May), more than 15 000 health-care facilities from 156 countries are participating in the WHO Save Lives: Clean Your Hands Initiative by committing to improve patient safety by practicing better hand hygiene.

who

WHO- Western Pacific Region celebrates Immunization Week 2012

MANILA, 20 APRIL 2012 –The World Health Organization (WHO) will launch World Immunization Week on 23 April in an effort to dramatically reduce the toll of death and illness from avoidable diseases.

who

WHO-Western Pacific Closes in on Its Measles Elimination Target

MANILA, 23 APRIL 2012 –The World Health Organization is closing in on its goal of eliminating measles in the Western Pacific Region by the end of this year.

who

WHO-Global Partners Launch New Plan to Control and Eliminate Measles and Rubella

24 APRIL 2012 | ATLANTA | GENEVA | NEW YORK | WASHINGTON, D.C –Today, the partners leading efforts to control measles announce a new global strategy aimed at reducing measles deaths and congenital rubella syndrome to zero.

who

WHO-Efforts to Eradicate Polio at Serious Risk of Failure Unless Adequate Resources are Identified

The emergency action plan to put polio eradication efforts back on track in Afghanistan, Nigeria and Pakistan was discussed at length during the meeting of WHO’s Strategic Advisory Group of Experts on immunization (SAGE) held from 10-12 April in Geneva.

who

WHO-World Immuniszation Week-Protect Your World :Get Vaccinated

Over 180 countries across the world are participating in the first ever World Immunization Week. The WHO-led initiative takes place from 21-28 April 2012 aims to raise awareness and encourage people everywhere to protect themselves and their families against vaccine-preventable diseases. It is also a time to focus on the fact that in this rapidly globalizing world, disease outbreaks can affect communities everywhere

who

WHO-Maintaining Oral health

18 April 2012 — Worldwide, 60–90% of school children and nearly 100% of adults have dental cavities. Globally, about 30% of people aged 65–74 have no natural teeth. The burden of oral diseases and other chronic diseases can be decreased by addressing common risk factors, such as reducing sugar, eating fruit and vegetables, ensuring proper oral hygiene as well as stopping tobacco use and decreasing alcohol consumption.

who

WHO-Dementia Cases Set to Triple by 2050 but Still Largely Ignored

11 APRIL 2012 | GENEVA – Worldwide, nearly 35.6 million people live with dementia. This number is expected to double by 2030 (65.7 million) and more than triple by 2050 (115.4 million). Dementia affects people in all countries, with more than half (58%) living in low- and middle-income countries. By 2050, this is likely to rise to more than 70%.

2_315

FIPPublication- IPJ Call for Articles Now Are Open

FIP is pleased to open the call for articles for the first IPJ of 2012. As this issue will be the last one before the Centennial, the theme is directly related to the Congress Programme: The future of pharmacy – how are we creating it?

2_315

FIP-Good Health Adds Life to Years – World Health Day 2012

Every year, World Health Day is celebrated on 7 April to mark the anniversary of the founding of WHO in 1948. Each year a theme is selected for World Health Day that highlights a priority area of concern for WHO. 

2_315

FIP-Newsletter 04,April,2012

who

WHO-New Incentives Needed to Encourage Health Research and Development for Developing Countries                                                                                                5 APRIL 2012 | GENEVA – New sources of funding are needed to stimulate health research specifically for diseases that affect people in developing countries, according to a report published today by an international expert group convened by WHO.

who

WHOWorld Health Day 2012 – Good Health Adds Life toYears

03 APRIL 2012 | GENEVA – On World Health Day (7 April), WHO is calling for urgent action to ensure that, at a time when the world’s population is ageing rapidly, people reach old age in the best possible health.

who

WHO-Childhood Tuberculosis Neglected , Depute Available Remedies

Childhood TB is a hidden epidemic

21 MARCH 2012 | GENEVA – Tuberculosis (TB) often goes undiagnosed in children from birth to 15 years old because they lack access to health services – or because the health workers who care for them are unprepared to recognize the signs and symptoms of TB in this age group. With better training and harmonization of the different programmes that provide health services for children, serious illness and death from TB could be prevented in thousands of children every year, WHO and Stop TB Partnership said today.

who

WHO-More evidence and better diagnostics needed before redefining severe forms of drug-resistant TB says WHO 

23 MARCH 2012 | GENEVA – Reports of tuberculosis (TB) cases with severe patterns of drug resistance are increasing, said experts who attended a WHO meeting in Geneva on 21-22 March. Participants stressed that the emergence of drug resistance should be a wake-up call for Ministries of Health. The group urged the global TB community to make greater efforts to prevent drug resistance and scale up provision of appropriate care and management to avoid a scenario where TB becomes incurable.

who

WHO-International Meeting of World Pharmacopoeias 

In an increasingly globalized world, international pharmaceutical standards are becomingly increasingly important to safeguard quality and improve access to medicines. For the first time in 10 years, representatives from pharmacopoeias from 23 countries came together on 29 February – 
2 March 2012 at WHO headquarters in Geneva and committed to working further towards harmonization and strengthening WHO’s role when developing global standards for the production and testing of medicines

2_315

FIP-Newsletter 5 March,2012

FIP HQ would like to remind Member Organisations that this year’s Centennial Congress will be packed full of events, all set to steer the future of pharmacy and healthcare on a global level.  See the “Schedule at a Glance” below and the website for more information.

who

WHO-More than 900 000 lives saved by protecting people living with HIV from TB

2 March 2012 — An estimated 910 000 lives were saved globally over six years by improving collaboration between TB and HIV services. In light of the experiences gained over the last six years, WHO is today launching an updated global policy to accelerate coordinated public health interventions to further reduce deaths from this dangerous combination of diseases.

who

WHOSuccessful strategies to safeguard medications

8 MARCH 2012 | GENEVA – A new book, The evolving threat of antimicrobial resistance – Options for action, launched by WHO, showcases examples of actions taken to slow down drug resistance and preserve the ability of medicine to effectively treat many infectious diseases. The steps taken by governments, health facilities and providers, and others are examples of what is recommended in the 2001 WHO Global Strategy for Containment of Antimicrobial Resistance.

who

WHO-Improve Africa’s Health 

who

WHOGuidance on Hormonal Contraceptive Use and HIV

who

 WHO-Drug Safty Alert

2_315

FIPWHO Takes Giant Stride in Promoting Medicines Safety Worldwide

2_315

FIP-Taiwan Society of Health-System Pharmacists (TSHP) – Twinning Programme for Good Pharmacy Practice

who

 

WHO(WHSR)Volume 2, Issue 4, October to December 2011

who

WHO-Vaccine Preventable Disease

who

WHO-African Trypanosomiasis

who

WHO-Pharmaceuticals Newsletter, No.6 2011

The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicines and legal actions taken by regulatory authorities across the world.

who

WHO-Treating TB in Rural Lesotho

Lesotho has one of the highest rates of new tuberculosis (TB) cases in the world. The lack of health-care facilities in remote areas makes it hard for people with TB to get tested and treated, so the disease spreads quickly through communities…

who

WHO-World AIDS Day 2011 Statement from Dr Mario Raviglione, Director of WHO Stop TB Department

Peaks, progress, impact – three words which reflect the concrete result strong leadership and funding have had on the TB epidemic and also on the HIV epidemic over the last decade…

who

WHO-Health Topics: Tuberculosis

Tuberculosis, or TB, is an infectious bacterial disease caused by Mycobacterium tuberculosis, which most commonly affects the lungs. It is transmitted from person to person via droplets from the throat and lungs of people with the active respiratory disease…

who

WHO-Meningitis Vaccination Campaign to Reach 300 Million by 2016

Chad has launched a mass campaign to vaccinate nearly 2 million people against meningitis A, the primary cause of epidemic meningitis in sub-Saharan Africa…

2_315

FIP-New Delhi Call to Action on Preserving the Power of Antibiotics

FIP Vice PResdient Dr Prafull Sheth was present in New Delhi in October to Chair a session during the First Global Forum on Bacterial Infections: Balancing Treatment Access and Antibiotic Resistance…

who

WHO-International Day of Persons with Disabilities

Around 15% of the world’s population, or one billion people, live with disabilities. People are often unaware of the great number of persons living with disabilities around the world and the challenges they face…

who

WHO-Significant Global Progress in Preventing and Treating HIV

The latest report by the WHO, UNICEF and UNAIDS Report on the global HIV/AIDS response indicates that increased access to HIV services resulted in a 15% reduction of new infections over the past decade and a 22% decline in AIDS-related deaths in the last five years…

2_315

FIP-Health Professionals Unite in WHPA Prague Call to Action, Urging Governments to Ramp Up Fight Against Falsified Medicines

In a first for the Central European region, national health professions organisations have discussed and endorsed the WHPA Prague Call to Action, to reduce the harmful impact of falsified medical products on patients and the public.

who

WHO-World AIDS Day

World AIDS Day on 1 December brings together people from around the world to raise awareness about HIV/AIDS and demonstrate international solidarity in the face of the pandemic…

who

WHO-Improving the Health of Women and Children in Afghanistan

The health system in Afghanistan continues to face many challenges. However, growing numbers of trained health-care workers are gradually helping to deliver improved health care to more and more people…

who

WHO-Election of the WHO Director-General

On 16 November, the sealed proposals were opened by the Chairman of the WHO Executive Board, Mr. Rahhal El Makkaoui. He has now advised WHO’s Member States that only one candidate has been proposed…

who

WHO-WHO Report on the Global Tobacco Epidemic, 2011 – Warning about the Dangers of Tobacco

who

WHO-Reducing Tobacco Use Lessens Chronic Obstructive Pulmonary Disease

An estimated 64 million people have chronic obstructive pulmonary disease (COPD)…

who

WHO-Healthy Lifestyles Prevent Diabetes

More than 346 million people worldwide have diabetes, and more than 80% of diabetes deaths occur in low- and middle-income countries…

2_315

FIP-World Diabetes Day – Pharmacists’ Contributions to Diabetes Care

Each year, World Diabetes Day is centered on a theme related to diabetes. Topics covered have included diabetes and human rights…

who

WHO–Global tuberculosis control 2011

who

 

WHOHealthy Ageing Important With Increasing Life Expectancy

who

 

 WHO-Warns of Consequences of Underfunding TB

 

who

 

WHO-The World Health Report

who

 

 WHO-The International Pharmacopoeia (Ph.Int.)

who

 

WHO-Measles outbreaks: Regions of the Americas, Europe and Africa

who

WHO Newsletter NO.4

WHO Pharmaceuticals Newsletter No.4

who

WHO Programmes and projects

Priority medicines for mothers and children 2011

who

WHO Programmes and projects

Access to Non Communicable Diseases Medicines

2_315

WHPA Taipei-Counterfeiting
WHPA Taipei Workshop on Counterfeiting of Medical Products

who

Emergency vaccination
Drought in Africa…

who

Director-General names …
WHO Director-General names Sir Liam Donaldson envoy for …

who

WHO warns against the …
WHO warns against the use of inaccurate blood tests for…

2_315

WHPA Taipei-Counterfeiting
WHPA Taipei Workshop on Counterfeiting of Medical Products

who

Health Warnings on …
Health Warnings on Tobacco Packaging

who

New world report shows …
New world report shows more than 1 billion people with…

who

Based research program …
Based research programme wins 2011 Gates Award for…

who

WHO-Pharmaceuticals Newsle
WHO-Pharmaceuticals Newsletter (No.3, 2011)

who

WHO-EHEC outbreak in Germa
International Health Regulations: EHEC outbreak in Germany

who

World Health Statistics
WHO – World Health Statistics 2011

who

The Access and Control …
WHO – The Access and Control Newsletter

who

Drug Information, Vol 25.
WHO – Drug Information, Volume 25, Number 1

who

WHO Newsletter NO.2
WHO – Pharmaceuticals Newsletter No. 2

who

WHO/FIP News Flash
WHO/FIP News Flash

who

Priority medicines for…
Priority medicines for mothers and children 2011

Salmonella (non-typhoidal)

Aug , 2013

Reference :

http://www.who.int/mediacentre/factsheets/fs139/en/index.html

Key facts

  • Salmonellosis, is one of the most common and widely distributed foodborne diseases, with tens of millions of human cases occurring worldwide every year.
  • Most cases of salmonellosis are mild, however, sometimes people die from salmonellosis. The severity of the disease may depend on host factors and the strain of salmonella.
  • Since the beginning of the 1990s, salmonella strains which are resistant to a range of antimicrobials have emerged and are now a serious public health concern.
  • Basic food hygiene practices, such as “cook thoroughly”, is recommended as a preventive measure against salmonellosis.

Overview

Salmonellosis is one of the most common and widely distributed foodborne diseases and is caused by the bacteria salmonella. It is estimated that tens of millions of human cases occur worldwide every year and the disease results in more than hundred thousand deaths. For salmonella species, over 2 500 different strains (called “serotypes” or “serovars”) have been identified to date. salmonella is a ubiquitous and hardy bacteria that can survive several weeks in a dry environment and several months in water.

While all serotypes can cause disease in humans, a few are host specific and can reside in only one or a few animal species, for example, Salmonella Dublin in cattle; and Salmonella Choleraesuis in pigs. When these particular serotypes cause disease in humans, it is often invasive and can be life-threatening. Most serotypes, however, are present in a wide range of hosts. Typically, such strains cause gastroenteritis, which is often uncomplicated and does not need treatment, but can be severe in the young, the elderly and patients with weakened immunity. This group features Salmonella Enteritidis and Salmonella Typhimurium, the two most important serotypes of salmonellosis transmitted from animals to humans in most parts of the world.

The disease

Salmonellosis is a disease caused by the bacteria salmonella. It is usually characterized by acute onset of fever, abdominal pain, diarrhoea, nausea and sometimes vomiting.  

The onset of disease symptoms occurs 6 – 72 hours (usually 12-36 hours) after ingestion of salmonella, and illness lasts 2-7 days.

Symptoms of salmonellosis are relatively mild and patients will make a recovery without specific treatment in most cases. However, in some cases, particularly in the very young and in the elderly patients, the associated dehydration can become severe and life-threatening.

Although large Salmonella outbreaks usually attract media attention, 60 to 80% of all salmonellosis cases are not recognized as part of a known outbreak and are classified as sporadic cases, or are not diagnosed as such at all.

Sources and transmission

  • Salmonella bacteria are widely distributed in domestic and wild animals. They are prevalent in food animals such as poultry, pigs, cattle; and in pets, including cats and dogs, birds and reptiles such as turtles.
  • Salmonella can pass through the entire food chain from animal feed, primary production, and all the way to households or food-service establishments and institutions.
  • Salmonellosis in humans is generally contracted through the consumption of contaminated food of animal origin (mainly eggs, meat, poultry and milk), although other foods, including green vegetables contaminated by manure, have been implicated in its transmission.
  • Person-to-person transmission through the faecal-oral route can also occur.
  • Human cases also occur where individuals have contact with infected animals, including pets. These infected animals often do not show signs of disease.

Treatment

Treatment in severe cases is symptomatic, electrolyte replacement (to provide electrolytes, such as sodium, potassium and chloride ions, lost through vomiting and diarrhoea) and rehydration.

Routine antimicrobial therapy is not recommended for mild or moderate cases in healthy individuals. This is because antimicrobials may not completely eliminate the bacteria and may select for resistant strains, which subsequently can lead to the drug becoming ineffective. However, health risk groups such as infants, the elderly and immunocompromised patients may need to receive antimicrobial therapy. Antimicrobials are also administered if the infection spreads from the intestine to other body parts. Because of the global increase of antimicrobial resistance, treatment guidelines should be reviewed on a regular basis taking into account the resistance pattern of the bacteria.

Prevention methods

Prevention requires control measures at all stages of the food chain, from agricultural production, to processing, manufacturing and preparation of foods in both commercial establishments and at home.

Preventive measures for Salmonella in the home are similar to those used against other foodborne bacterial diseases (see “Recommendations for food handlers” below).

Some animals can also pass the bacteria directly to people. The contact between infants/young children and pet animals (cats, dogs, turtles etc.) needs careful supervision.

National/regional surveillance systems are important means to detect and respond to salmonellosis and other enteric infections in early stages, and thus to prevent them from further spreading.

Recommendations for the public and travellers

  • Ensure food is properly cooked and still hot when served.
  • Avoid raw milk and products made from raw milk. Drink only pasteurized or boiled milk.
  • Avoid ice unless it is made from safe water.
  • When the safety of drinking water is questionable, boil it or if this is not possible, disinfect it with a reliable, slow-release disinfectant agent (usually available at pharmacies).
  • Wash hands thoroughly and frequently using soap, in particular after contact with pets or farm animals, or after having been to the toilet.
  • Wash fruits and vegetables carefully, particularly if they are eaten raw. If possible, vegetables and fruits should be peeled.
  • When travelling, refer to WHO’s brochure A guide on safe food for travellers.

Recommendations for food handlers

  • Both professional and domestic food handlers should be vigilant while preparing food and should observe hygienic rules of food preparation.
  • Professional food handlers who suffer from fever, diarrhoea, vomiting or visible infected skin lesions should report to their employer immediately.
  • The WHO Five Keys to Safer Food serve as the basis for educational programmes to train food handlers and educate consumers. They are especially important in preventing food poisoning. The Five Keys are:
    • Keep clean.
    • Separate raw and cooked.
    • Cook thoroughly.
    • Keep food at safe temperatures.
    • Use safe water and raw materials.

Recommendations for producers of fruits and vegetables

The WHO “Five keys to growing safer fruits and vegetables” is an educational manual for rural workers, including small farmers who grow fresh fruits and vegetables for themselves, their families and for sale in local market. It provides them with key practices to prevent microbial contamination of fresh produces during planting, growing, harvesting and storing.

The five keys practices are:

  • Practice good personal hygiene.
  • Protect fields from animal faecal contamination.
  • Use treated faecal waste.
  • Evaluate and manage risks from irrigation water.
  • Keep harvest and storage equipment clean and dry.

WHO response

  • WHO promotes the strengthening of food safety systems, promoting good manufacturing practices and educating retailers and consumers about appropriate food handling and avoiding contamination. Education of consumers and training of food handlers in safe food handling is one of the most critical means to prevent foodborne illnesses including salmonellosis.
  • WHO strengthens and enhances the capacities of national and regional laboratories in the surveillance of Salmonella, the other major foodborne pathogens and antimicrobial resistance in Salmonella and campylobacter from humans, food and animals through the network called Global Foodborne Infections Network (GFN) .
  • WHO’s main tool to assist Member States in surveillance, coordination and response to outbreaks is the use of the International Network of Food Safety Authorities (INFOSAN) . which links national authorities in Member States in charge of managing food safety events. This network is managed jointly by FAO and WHO.

[FIP] European Summit on Hospital Pharmacy

Aug 01 , 2013

Reference :

http://www.pharm.org.tw/index.php?option=com_content&view=article&id=896:fip-european-summit-on-hospital-pharmacy&catid=28:fip&Itemid=67

FIP Advancing Pharmacy Worldwide
International Pharmaceutical Federation
August 2013
Contacting fip
PO Box 84200
2508 AE The Hague
The Netherlands

Tel.: +31-70-3021970
Fax: +31-70-3021999
Email: fip@fip.org

Did you know
FIP is the global federation of national associations representing 2 million pharmacists and pharmaceutical scientists around the world.
To change your contact information or to unsubscribe, please use this link.
Here you can also change your preferences.

 

 

NPS news : Rivaroxaban (Xarelto) for treatment of deep vein thrombosis and pulmonary embolism, and for prevention of venous thromboembolism recurrence

    Aug , 01  2103

     

    Reference :

    http://www.nps.org.au/publications/health-professional/nps-radar/latest-issue/rivaroxaban-dvt-pe

    • An alternative to INR-adjusted warfarin with initial heparin for the treatment of symptomatic DVT (without symptomatic PE) or PE.
            Efficacy and safety were studied in people with acute, symptomatic proximal DVT without PE, and in people with acute symptomatic PE with or without DVT, over 3, 6 or 12 months.
    • Rivaroxaban is non-inferior to enoxaparin plus warfarin for preventing VTE (DVT or PE) recurrence.
            In trials VTE recurrence, major or clinically relevant non-major bleeding, and mortality were similar with rivaroxaban compared with enoxaparin plus either warfarin or acenocoumarol.a
    • For initial treatment of acute DVT or PE the dose is rivaroxaban 15 mg twice a day for the first 3 weeks then 20 mg once a day.
                Continue treatment for as long as the risk of VTE recurrence persists, balancing benefits and harms and patient preference.        
    • For continuing treatment in people with a history of VTE the dose is 20 mg once a day.
            In trials rivaroxaban reduced recurrence of VTE in these people, but increased incidence of bleeding compared with placebo.
    • There is no antidote to the anticoagulant effects of rivaroxaban and no readily available and validated method of monitoring its activity in a primary care setting.
            Routine coagulation monitoring is not possible but routine clinical monitoring is essential. Advise patients to seek urgent medical attention for unexplained bruising, blood in the urine or black stools.
    • Bleeding risk may be higher in people with renal impairment.
            Very few people with renal impairment were included in trials. Do not use in people with severe renal impairment (CrCl < 30 mL/min).
    aAcenocoumarol is not marketed in Australia.    

    NPS news : New reporting mechanism for antipsychotic use in aged care

    Aug 12 , 2013

    Reference :

    http://www.nps.org.au/media-centre/media-releases/repository/New-reporting-mechanism-for-antipsychotic-use-in-aged-care

    NPS MedicineWise and Webstercare have collaborated for the first time on a project to assist in the review of antipsychotic medicine use in residential aged care facilities.

    The new functionality in the Webstercare Medication Management Software (MMS) allows pharmacists to produce a report on the use of antipsychotic medicines in each residential aged care facility for which they supply medicines.

    NPS MedicineWise CEO Dr Lynn Weekes AM says that evidence suggests there is extensive off label use of antipsychotics for dementia patients in residential aged care.

    “While they can occasionally be effective for short term aggression and psychotic symptoms – we see them being used too often, for too long at high doses and in dangerous combinations,” says Dr Weekes.

    “Incorrect use of these medicines can have serious consequences including an increased risk of falls, hip fractures and even death.”

    The new reporting mechanism will enable pharmacists to provide information to staff working in residential aged care facilities and aid them in understanding, analysing and effectively managing the appropriate use of antipsychotic medicines for their residents.

    Dr Weekes says that the new, in-depth quality use of medicines (QUM) report in the Webstercare software provides staff with objective measurements that enable them to establish a baseline and identify patterns of use over time, and even compare their antipsychotic medicine use with published studies.

    “By partnering with Webstercare on this project, we hope to ensure a more appropriate use of antipsychotics in residential aged care facilities in the long term,” she says.

    Webstercare CEO Mr Gerard Stevens AM says that NPS MedicineWise and Webstercare are committed to supporting the aged care industry in its endeavour to ensure the safe use of antipsychotics and to improve care in line with evidence-based guidelines.

    “The QUM report identifies residents who may benefit from a medicine review from their doctor,” says Mr Stevens.

    “It will provide valuable data for the local Medicine Advisory Committees within residential aged care facilities to review at their regular meetings. The residential aged care facilities that were part of the pilot program received it very positively, saying that the report has the capability of changing practice.

    “The report could also help a residential aged care facility meet the Accreditation Standards for Residential Aged Care in areas such as continuous improvement, medication management and behavioural management.”

    The QUM reports are available as part of pharmacies’ latest software update of Webstercare’s Professional and Professional Plus Medication Management Software (MMS).

     

    Stop smoking — what works for your patients?

    Aug 14 , 2013

    Reference :

    http://www.nps.org.au/health-professionals/health_news_evidence/2013/stop-smoking-what-works

    Although rates of smoking have declined over the past decade there are still around 2.8 million Australians who smoke.1 Of all the behavioural risk factors associated with poor health, smoking is the leading cause of preventable disease and premature death.

    Most smokers want to quit, and with the increases in the tobacco excise, quitting may become an even more important financial consideration for many smokers.2 However, for the proportion of smokers who are dependent on nicotine, unassisted attempts to quit will usually be unsuccessful.

    Pharmacological intervention may help smokers who want to quit to do so successfully. However, of the three agents approved for use in Australia — nicotine replacement therapy, varenicline and bupropion — which one makes the most difference to smokers?

    A new Cochrane meta-analysis may provide some clarity on which agent is the most effective in helping people quit smoking.

     

    iBulletin 130815

    Aug 15 2013

    Reference :

    http://www.mps.org.my/newsmaster.cfm?&menuid=37&action=view&retrieveid=3794

    PHARMACY IN HEALTH TRANSFORMATION SEMINAR

    Changes in the practice of pharmacy are already taking place. How will this change affect you? How will you transform in this change ? Are you able to recognise the transformation that is taking place?
     
    Join us at the coming seminar on 20th Sep to find out where is the Pharmacy profession heading towards, and are you part of the transformation, or are you still anchor down. 

    For the first 150 registered participants a copy of the BNF (Past Edition) will be given away free of charge during the seminar.

    Date: 20th Sep 2013
    Venue: One World Hotel, Bandar Sunway, Petaling Jaya

    >> Program and Registration 

    alt

    PHARMACY NIGHT – AN AWARD PRESENTATION NIGHT

    In the evening of 20th Sep, the annual fraternity pharmacy Night will take place. It will be a black tie event and the winners of the Outstanding Pharmacists Awards will be announced, and award presented

    The Awards will be presented in the various categories, namely in Administration, Academia, Community, Hospital, Industrial and including Promising Young Pharmacist.
    The registration form is incorporated in the Seminar form. 

    >>  Program and Registration

    alt

    EGM 21-SEPTEMBER, 2013

    All members of MPS are to take note that the Extraordinary General Meeting that was proposed at the previous AGM shall now take place on 21st Sep at Wisma MPS, 10am. The agenda is to present the first independently public audited accounts of the Society.

    Following the EGM, there shall be an Open Forum for members to discuss matters affecting the profession. If you have matters to raise, kindly email to mspharm@po.jaring.my with the subject title : Forum2013 – “your name” eg Forum2013 – Adam. 

    alt

    MPS OUTSTANDING PHARMACIST OF THE YEAR AWARD 2013

    Application is now open for members to be nominated as the MPS Outstanding Pharmacist of the Year Award 2013 in the following arenas:

    1. Excellence in Pharmacy Administration
    2. Excellence in Academia
    3. Excellence in Community Pharmacy
    4. Excellence in Hospital Pharmacy
    5. Excellence in Industrial Pharmacy
    6. Most Promising Young Pharmacist

    All nominations must be in writing and to be submitted to the MPS Secretariat by 20th August 2013 by email.  Supportive documents should be summarised and also email.

    The winners will be announced at the forthcoming MPS Pharmacy Night on 20th Sep at the One World Hotel.

    Furthur details of the award can be found at the MPS website

    >>  Click here for more information.

    alt

    MELAKA AREA – HALF DAY WORKSHOP AND DINNER 2013

    The Melaka Area shall be organising a Half-Day workshop follow by the annual dinner on 9th Nov 2013.
    Topics for the seminar include update in therapy, dispensing separation experience and also preparing for retirement before your boss does. 

    >>  Program and registration  

    alt

    DIALOGUE WITH SELANGOR ENFORCEMENT

    The Selangor Enforcement has invited MPS to a dialogue session on 22nd Aug. This is a good step as it open the door to further develop the already good rapport and co-operation among MPS and government agencies, especially related to pharmacy.

    Members are invited to submit issues to the MPS so that they can be brought up at the dialogue. Kindly email to mspharm@po.jaring.my with the subject matter “Dialogue – Your name” eg Dialogue – Adam. 

    GENERIC MEDICINES POLICIES IN THE ASIA PACIFIC REGION: WAYS FORWARD
    Nguyen TA, Hassali MA, McLachlan A. Generic medicines policies in the Asia Pacific region: ways forward. WHO South- East Asia J Public Health 2013;2:72-4.

    Generic medicines are a key strategy used by governments and third‑party payers to contain medicines costs and improve the access to essential medicines. This strategy represents an important opportunity provided by the global intellectual property regimes to discover and develop copies of original products marketed by innovator companies once the patent protection term is over. While there is an extensive experience regarding generic medicines policies in developed countries, this evidence may not translate to developing countries. The generic medicines policies workshop at the Asia Pacific Conference on National Medicines Policies 2012 provided an important opportunity to discuss and document country‑specific initiatives for improving access to and the rational of use of generic medicines in the Asia Pacific region. Based on the identified barriers and enablers to implementation of generic medicines policies in the region, a set of future action plans and recommendations has been made.  Download PDF document here.

    alt

    NEWS FROM AROUND THE UNIVERSITY – CUCMS

    Pharmacist as a profession

    Majority of the people in Felda Sungai Koyan, Pahang were not familiar with the profession as a pharmacist before until a group of pharmacy students and lecturers who are also practicing pharmacists from various streams and pharmacy specialty like community pharmacist, clinical pharmacist and industrial pharmacist from Faculty of Pharmacy, Cyberjaya University College of Medical Sciences (CUCMS) visited them under the yearly community project known as KAMU (Kenali Ubat Anda). 

    Among other activities in KAMU, such as free health screening and health counseling, the Home Medicine and Medication Review (HMR) was the favorite where the Bachelor of Pharmacy students and pharmacy lecturers teamed up and went from house to house in the Felda area to review and give advice regarding their medications, compliance, difference between after food and before food, storage, drug interactions and lifestyle modification advice towards a better health. During the HMR, a lot of medication related problems were detected. To mention some, for example, the storage of the medicines was taken for granted when some patients store it together with food and some still keep the long expired medicines. Compliance was another problem detected where some of them never take their medications even though they never missed their check-ups with their doctors. 

    At Cyberjaya University College of Medical Sciences (CUCMS), our strong team of experienced lecturers is fully committed to educate and train our students with updated pharmacy knowledge, skills and hands on practice. Students are exposed to the profession early through visits, community pharmacy attachment, primary care attachment, industrial training and clinical pharmacy attachments at various practice sites around Malaysia, our designated hospitals and primary care clinics. Sufficient training and hands-on experience are provided such in-patient interview; counseling and ward round with medical doctors. Competencies are assessed continuously to ensure excellent pharmacy graduates with the passion to care are produced by the university. 

    – See more at: http://www.mps.org.my/newsmaster.cfm?&menuid=37&action=view&retrieveid=3794#sthash.A3p1ctqN.dpuf

    iBulletin 130801

    Aug , 13 2013

    Reference :

    http://www.mps.org.my/newsmaster.cfm?&menuid=37&action=view&retrieveid=3783

    FROM THE PRESIDENT’S DESK

    Dear Members,

    A meeting was recently held on 23-7-13 at the Pharmaceutical Services Division, chaired by YBhg Dato’ Eisah to discuss “Good Governance for Medicine – GGM”.

    It was highlighted that good governance for medicines is important. According to the 2010 World Health report, global health expenditure has reached US$4.1 trillion per year. Expenditure on pharmaceuticals accounts for some US$880 billion of this total.

    According to the Ministry of Health figures, Malaysia is expected to spend RM17 billion on health in 2013 of which RM2.1 billion is for pharmaceuticals without taking into consideration private spending.

    The GGM programme was launched in 2004 with the goal of contributing to health systems strengthening and preventing corruption by promoting good governance in the pharmaceutical sector. In Malaysia, the National GGM Program has been well developed with GGM guidelines and Training of the Trainees Module.

    Two documents have been published by the Division namely :-

    1. Guidelines on Giving and Receiving gifts for Civil servants under the Pharmacy Program, Ministry of Health Malaysia.
    2. Guidelines for Pharmacy Members in dealing with Pharmaceutical Company Representatives and Suppliers.

    The GGM Program of Malaysia is currently in Phase III: Implementation of National GGM Program  5 workshops were conducted in 2012 to develop the GGM Trainer of Trainees (TOT) Module.

    The Pharmaceutical Services Division has worked hard to put in the roadmap for GGM and pharmacist professionals throughout the Country are urged to uphold the Principles of Good Governance of Medicines in their practice.

    Let us continue to implement best  practices in Pharmacy and keep our banner flying high.

    Yours in MPS

    Datuk Nancy Ho
    President

    – See more at: http://www.mps.org.my/newsmaster.cfm?&menuid=37&action=view&retrieveid=3783#sthash.QZxwFbUR.dpuf